Topical calcineurin inhibitors in eczema and cancer association: A cohort study
Author:
Publisher
Informa UK Limited
Subject
Dermatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference36 articles.
1. Whatâs new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 1. Definitions, causes and consequences of eczema
2. The epidemiology of atopic dermatitis
3. Food and Drug Administration. FDA Approves Updated Labeling with Boxed Warning and Medication Guide for Two Eczema Drugs, Elidel and Protopic. 2006. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm153941.htm. Accessed June 21, 2014.
4. Association Between Exposure to Topical Tacrolimus or Pimecrolimus and Cancers
5. Risk of Lymphoma Following Exposure to Calcineurin Inhibitors and Topical Steroids in Patients with Atopic Dermatitis
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study;Journal of Dermatological Treatment;2023-07-03
2. Association Between the Use of Topical Calcineurin Inhibitors and the Risk of Cancer Among Patients with Atopic Dermatitis: A Nationwide, Population-Based, Retrospective Cohort Study;American Journal of Clinical Dermatology;2023-06-06
3. Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis;The Lancet Child & Adolescent Health;2023-01
4. Eczema as a protective factor for brain cancer: a meta-analysis;BMC Cancer;2022-12-29
5. Topische Calcineurininhibitoren und das Risiko für Lymphome: eine systematische Übersicht und Metaanalyse;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3